Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus... The aim of this study was to observe the effects of neoadjuvant therapy with irinotecan and 5-fluorouracil (5-FU)/folinic acid (FA) on the resection rate and survival of colorectal cancer patients with initially unresectable hepatic metastases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Oncology Pubmed

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.

Annals of Oncology , Volume 15 (6): -923 – Oct 5, 2004

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.


Abstract

The aim of this study was to observe the effects of neoadjuvant therapy with irinotecan and 5-fluorouracil (5-FU)/folinic acid (FA) on the resection rate and survival of colorectal cancer patients with initially unresectable hepatic metastases.

Loading next page...
 
/lp/pubmed/neoadjuvant-treatment-of-unresectable-liver-disease-with-irinotecan-Cy5tfDEan8

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0923-7534
DOI
10.1093/annonc/mdh217
pmid
15151951
Publisher site
See Article on Publisher Site

Abstract

The aim of this study was to observe the effects of neoadjuvant therapy with irinotecan and 5-fluorouracil (5-FU)/folinic acid (FA) on the resection rate and survival of colorectal cancer patients with initially unresectable hepatic metastases.

Journal

Annals of OncologyPubmed

Published: Oct 5, 2004

There are no references for this article.